Ximerex Overview

  • Founded
  • 1993

Founded
  • Status
  • Private

  • Employees
  • 7

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $6.84M

  • Investors
  • 1

Ximerex General Information

Description

Provider of biotechnological research services. The company develops technology that provides cells, tissues, and organs from donor pigs for transplantation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • 2614 North 161st Avenue
  • Omaha, NE 68116
  • United States
+1 (402) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ximerex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jun-2013 $6.84M Completed Generating Revenue
2. Grant 01-Jun-2005 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Ximerex’s complete valuation and funding history, request access »

Ximerex Patents

Ximerex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090214482-A1 Transgenic mammals expressing human preproinsulin Abandoned 13-Apr-2005 00000000000 0
AU-2003270728-B2 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells Ceased 19-Sep-2002 0000000000
US-20100075414-A1 Growth of foreign cells after conditional and selective destruction of fetal host cells Abandoned 19-Sep-2002 0000000000 0
CA-2498711-A1 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells Granted 19-Sep-2002 0000000000
AU-2003270728-A1 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells Granted 19-Sep-2002 C12N5/0081
To view Ximerex’s complete patent history, request access »

Ximerex Executive Team (1)

Name Title Board Seat Contact Info
William Beschorner MD Founder, President & Chief Scientific Officer
To view Ximerex’s complete executive team members history, request access »

Ximerex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ximerex Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Ximerex’s complete investors history, request access »